EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015–21

Lavinia Fabeni, Daniele Armenia, Isabella Abbate, Roberta Gagliardini, Valentina Mazzotta, Ada Bertoli, William Gennari, Federica Forbici, Giulia Berno, Lorenzo Piermatteo, Vanni Borghi, Carmela Pinnetti und 16 weitere

Journal of Antimicrobial Chemotherapy · 2024

DOI: 10.1093/jac/dkae189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Lavinia Fabeni und 27 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Drug Resistance, Viral, Phylogeny. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Aviralia, AVIRALIA Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transmitted drug resistance (TDR) is still a critical aspect for the management of individuals living with HIV-1. Thus, its evaluation is crucial to optimize HIV care.

Methods

Overall, 2386 HIV-1 protease/reverse transcriptase and 1831 integrase sequences from drug-naïve individuals diagnosed in north and central Italy between 2015 and 2021 were analysed. TDR was evaluated over time. Phylogeny was generated by maximum likelihood. Factors associated with TDR were evaluated by logistic regression.

Results

Individuals were mainly male (79.1%) and Italian (56.2%), with a median (IQR) age of 38 (30–48). Non-B infected individuals accounted for 44.6% (N = 1065) of the overall population and increased over time (2015–2021, from 42.1% to 51.0%, P = 0.002). TDR prevalence to any class was 8.0% (B subtype 9.5% versus non-B subtypes 6.1%, P = 0.002) and remained almost constant over time. Overall, 300 transmission clusters (TCs) involving 1155 (48.4%) individuals were identified, with a similar proportion in B and non-infected individuals (49.7% versus 46.8%, P = 0.148). A similar prevalence of TDR among individuals in TCs and those out of TCs was found (8.2% versus 7.8%, P = 0.707). By multivariable analysis, subtypes A, F, and CFR02_AG were negatively associated with TDR. No other factors, including being part of TCs, were significantly associated with TDR.

Conclusions

Between 2015 and 2021, TDR prevalence in Italy was 8% and remained almost stable over time. Resistant strains were found circulating regardless of being in TCs, but less likely in non-B subtypes. These results highlight the importance of a continuous surveillance of newly diagnosed individuals for evidence of TDR to inform clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsDrug Resistance, ViralPhylogenyHumansItalyMaleAdultFemaleMiddle AgedPrevalenceAnti-HIV AgentsGenotypeHIV ProteaseYoung Adult

Substanzen

Anti-HIV AgentsHIV Protease

Autor:innen und Institutionen

  • Laboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Departmental Faculty, UniCamillus, Saint Camillus International University of Health Sciences, Rome, Italy.
  • Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Laboratory of Virology, Department of Laboratory Medicine, University Hospital Tor Vergata, Rome, Italy.
  • Molecular Microbiology and Virology Unit, Department of Laboratory Medicine and Pathological Anatomy, Policlinic of Modena, University of Modena and Reggio Emilia, Modena, Italy.
  • Department of Biology, University of Rome Tor Vergata, Rome, Italy.

ORCID-Profile: Alessandra Vergori, Loredana Sarmati, Enrico Girardi

Förderung

  • Fondazione Aviralia
  • AVIRALIA Foundation

Zitieren

APA

Fabeni, L., Armenia, D., Abbate, I., Gagliardini, R., Mazzotta, V., Bertoli, A., Gennari, W., Forbici, F., Berno, G., Piermatteo, L., Borghi, V., Pinnetti, C., Vergori, A., Mondi, A., Parruti, G., Di Sora, F., Iannetta, M., Lichtner, M., Latini, A., …, & Italian HIV Drug Resistance Group (2024). HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015–21. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae189

Vancouver

Fabeni L, Armenia D, Abbate I, Gagliardini R, Mazzotta V, Bertoli A, et al. HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015–21. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae189

BibTeX
@article{Fabeni2024,
  author = {Fabeni, Lavinia and Armenia, Daniele and Abbate, Isabella and Gagliardini, Roberta and Mazzotta, Valentina and Bertoli, Ada and Gennari, William and Forbici, Federica and Berno, Giulia and Piermatteo, Lorenzo and Borghi, Vanni and Pinnetti, Carmela and Vergori, Alessandra and Mondi, Annalisa and Parruti, Giustino and Di Sora, Fiorella and Iannetta, Marco and Lichtner, Miriam and Latini, Alessandra and Mussini, Cristina and Sarmati, Loredana and Perno, Carlo Federico and Girardi, Enrico and Antinori, Andrea and Ceccherini-Silberstein, Francesca and Maggi, Fabrizio and Santoro, Maria Mercedes and Italian HIV Drug Resistance Group, Italian HIV Drug Resistance Group},
  title = {HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015–21},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  doi = {10.1093/jac/dkae189}
}
Kostenlos starten →